More information on trial site investigators needed

Despite the importance of site investigators to the success of multicentre clinical trials, inadequate public information is available about their recruitment performance.

In this week's , Rafael Dal-Ré and colleagues argue that that sponsors should disclose the recruitment targets of all site on before a trial starts, as well as their final recruitment.

Information on issues that could have affected recruitment should also be provided. This information will be of interest to different stakeholders such as patient organizations, sponsors, and MCT networks, say the authors.

The authors state that: "Disclosing all site investigators' recruitment figures could prompt queries to the sponsor from the scientific community about regional subgroup analyses, to be able to assess if ethnic or standard-of-care differences have an impact on treatment outcomes."

Explore further

UCSF experts highlight need for innovation in recruiting participants for clinical trials

More information: Dal-Ré R, Moher D, Gluud C, Treweek S, Demotes-Mainard J, et al. (2011) Disclosure of Investigators' Recruitment Performance in Multicenter Clinical Trials: A Further Step for Research Transparency. PLoS Med 8(12): e1001149. doi:10.1371/journal.pmed.1001149
Citation: More information on trial site investigators needed (2011, December 27) retrieved 25 September 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments